WHO ICTRP trial
A study to investigate the possible interaction between clobazam and…
EUCTR2014-002942-33-GB · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2014-002942-33-GB |
|---|---|
| Public title | A study to investigate the possible interaction between clobazam and cannabidiol. |
| Scientific title | A phase 2, double-blind, randomized, placebo-controlled study to investigate possible drug-drug interactions between clobazam and cannabidiol (GWP42003-P) |
| Primary sponsor | GW Research Ltd |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | Spain;United Kingdom |
| Conditions | MedDRA version: 18.1 Level: PT Classification code 10073677 Term: Severe myoclonic epilepsy of infancy System Organ Class: 10010331 - Congenital, familial and genetic disorders ;Therapeutic area: Diseases [C] - Nervous System Diseases [C10] |
| Interventions | Product Name: Cannabidiol (CBD) Product Code: GWP42003-P Pharmaceutical Form: Oral solution INN or Proposed INN: N/A CAS Number: 13956-29-1 Current Sponsor code: GWP42003-P Other descriptive name: CANNABIDIOL Concentration unit: mg/ml… |
| Registration date | Feb 13, 2015 |
| Target size | 20 |
| Secondary IDs | GWEP1428 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: